Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024141 (
systemic lupus erythematosus
)
44,322
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In this study, the association between the
systemic lupus erythematosus
(
SLE
) susceptibility and the new candidate genes, IFNA1, IFNA2 and
IFNA5
genes, major interferon-alpha subtypes, in responses to viral infection was investigated. Allele and genotype frequencies of each marker were compared between 150
SLE
patients and 150 healthy control subjects. This study indicated that the A/A genotype of
IFNA5
(-2529) and the G/G genotype of IFNA1 (-1823) were associated with the protection of
SLE
disease in a recessive model [P(c) = 0.03, P = 0.01, odds ratio (OR) = 0.4, 95% confidence interval (CI) = 0.2-0.8 and P(c) = 0.09, P = 0.03, OR = 0.5, 95% CI = 0.2-0.9, respectively). Multifactor dimensionality reduction analysis showed a marginal interaction between
IFNA5
(-2529) and IFNA1 (-1823) gene, with a cross-validation consistency of 10 of 10 and a prediction error of 46% (permutation P-value = 0.05). This is the first report of positive association of IFNA gene in
SLE
, especially the role of specific subtypes IFNA1 and
IFNA5
.
...
PMID:Genetic association of interferon-alpha subtypes 1, 2 and 5 in systemic lupus erythematosus. 1900 Jan 44